$JOBY · Joby Aviation, Inc.
Joby Aviation reported Q3 FY2026 results on November 4, 2026: revenue of $55.1M (primarily from Blade), GAAP EPS of $(0.22), and $2.2B in cash and short-term investments as of September 30, 2026. The company raised full-year 2026 revenue guidance 15% to a range of $135M–$140M and guided second-half 2026 cash use of $385M–$415M. It also announced a planned acquisition of Resonant Sciences, an EBITDA-positive defense firm with $100M+ trailing-twelve-month revenue.
- Q3 revenue $55.1M, primarily from Blade, which flew a record 44,000+ passengers.
- FY2026 revenue guidance raised 15% to $135M–$140M.
- GAAP EPS of $(0.22) for Q3 FY2026.
- $2.2B in cash, cash equivalents, and short-term investments as of September 30, 2026.
- Planned Resonant Sciences acquisition: $100M+ trailing-twelve-month revenue, closing expected early 2027.
Extended-hours last trade $5.36, up +6.14% vs the $5.05 regular close, reflecting a positive reaction to the guidance raise and defense expansion.
Joby pairs a 15% guidance raise with a scaled defense acquisition and certification milestones, signaling accelerating commercialization momentum.
Joby's eVTOL progress—first eIPP flights in Texas and Florida, 17 aircraft in production, and FAA 'for credit' testing—positions it ahead of peers in the urban air mobility race toward certification.
Air Force contracts remain subject to government funding and appropriations constraints; the Resonant Sciences acquisition carries integration, retention, and unanticipated-cost risks, and closing depends on regulatory approvals.